Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK (KNSA)

CUSIP: G52694109

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / CLASS A COMMON STOCK
Shares outstanding
45,795,795
Total 13F shares
35,248,812
Share change
+35,129,168
Total reported value
$658,014,093
Put/Call ratio
95%
Price per share
$18.67
Number of holders
126
Value change
+$655,780,340
Number of buys
123

Quarterly Holders Quick Answers

What is CUSIP G52694109?
CUSIP G52694109 identifies KNSA - Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK (KNSA) as of Q2 2024

As of 30 Jun 2024, Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK (KNSA) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,248,812 shares. The largest 10 holders included BlackRock Inc., Fairmount Funds Management LLC, HHLR ADVISORS, LTD., BAKER BROS. ADVISORS LP, Rubric Capital Management LP, BRAIDWELL LP, MORGAN STANLEY, STATE STREET CORP, Pictet Asset Management Holding SA, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 126 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.